Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003 Jun 15;32(1):60.
doi: 10.1016/s0212-6567(03)78858-1.

[Raynaud's phenomenon and sclerodermia]

[Article in Spanish]
J Ezquerra Gadea, I López Larrayoz, F García Cores, M García Muñoz
Case Reports

[Raynaud's phenomenon and sclerodermia]

[Article in Spanish]
J Ezquerra Gadea et al. Aten Primaria. .
No abstract available

PubMed Disclaimer

References

    1. Riera G., Vilardell M., Vaqué M., Fonollosa V., Bermejo B. Prevalence of Raynaud’s phenomenon in a healthy. Spanish population. J Rheumatol. 1993;20:66–69. - PubMed
    1. Rodeeheffer R.J., Rommer J.A., Wigley F., Smith C.R. Controlled double-blib tiral on nifede in the treatment of Raynaud’s phenomenon. N Engl J Med. 1983;308:880–883. - PubMed
    1. Sturgill M.G., Seibold J.R. Rational use of calcium-chanel antagonists in Raynaud’s phenomenon. Curr Opinion Rheumatol. 1998;10:584–588. - PubMed
    1. Pancera O., Sansone S., Secchi S., Covi G., Lechi A. The effects of thromboxane A2 inhibition (picotamida) and angiotensin II receptor blockade (losartán) in primary Raynaud’s phenomenon. J Int Med. 1997;242:373–376. - PubMed
    1. Prost A., Bordas J.M., Benito P. Reumatología en Atención Primaria. Aula Médica; Madrid: 2001. Esclerodermia sistémica; pp. 249–264.